SPONSOR
Radboud University Medical Center
Total Trials
9
Recruiting
9
Phases
Phase 4, Phase 1, Phase 2
Conditions studied: OncologySepsisNeuroinflammatory ResponseImmunosuppresionEndotoxemiaAnakinraDexamethasoneTocilizumabCentral Core DiseaseMulti-Minicore Disease
Radboud University Medical Center is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Oncology, Sepsis, Neuroinflammatory Response, Immunosuppresion.
The trial portfolio spans Phase 4, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Radboud University Medical Center
How many clinical trials has Radboud University Medical Center sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Radboud University Medical Center, of which 9 are actively recruiting participants. These trials cover conditions including Oncology, Sepsis, Neuroinflammatory Response. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Radboud University Medical Center research focus on?
Radboud University Medical Center clinical trials span Oncology, Sepsis, Neuroinflammatory Response, Immunosuppresion, Endotoxemia, and additional conditions. The research pipeline includes Phase 4, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Radboud University Medical Center clinical trial?
To participate in a Radboud University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Radboud University Medical Center trials with current recruitment status updated daily.
Clinical Trials by Radboud University Medical Center
NCT07680556
Recruiting
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Oncology
NCT06624436 Phase 4
Recruiting
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Sepsis
NCT06157268
Recruiting
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
Central Core Disease
NCT06332560
Recruiting
Pain in Endometriosis And the Relation to Lifestyle
Endometriosis
NCT05773859 Phase 1, Phase 2
Recruiting
NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer
Epithelial Ovarian Cancer
NCT07156552
Recruiting
Protein Supplementation and Resistance Training to Prevent Fat-Free Mass Loss Following Metabolic-Bariatric Surgery
Bariatric Surgery
NCT00825929
Recruiting
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
HIV Infections
NCT06993142
Recruiting
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Parkinson Disease
NCT07334275
Recruiting
Detection of Minimal Residual Disease Post-prostatectomy
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology